Antivascular endothelial growth factor treatment in pseudoxanthoma elasticum patients

Developments in Ophthalmology

Volumn 46, Issue , 2010, Pages 96-106

  Verbraak, Frank D ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; RANIBIZUMAB; VASCULOTROPIN A;

ANGIOID STREAK; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; PATHOLOGY; PSEUDOXANTHOMA ELASTICUM; RECESSIVE GENE; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANGIOID STREAKS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; GENES, RECESSIVE; HUMANS; INJECTIONS, INTRAOCULAR; PSEUDOXANTHOMA ELASTICUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 84925967946     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000320012     Document Type: Article

References (45)

1. Chassaing N, Martin L, Calvas P, Le BM, Hovnanian A: Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet 2005;42:881-892.
2. Finger RP, Charbel I P, Ladewig MS, Gotting C, Szliska C, Scholl H P, et al: Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol 2009;54:272-285.
3. Plomp AS, Toonstra J, Bergen AA, van Dijk MR, de Jong PT: Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings. Am J Med Genet A 2010;152A:1049-1058.
4. Fabbri E, Forni GL, Guerrini G, Borgna-Pignatti C: Pseudoxanthoma- elasticum-like syndrome and thalassemia: an update. Dermatol Online J 2009;15:7.
5. Laube S, Moss C: Pseudoxanthoma elasticum. Arch Dis Child 2005;90:754-756.
6. Li Q, Jiang Q, Pfendner E, Varadi A, Uitto J: Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Dermatol 2009;18:1-11.
7. Bergen AA, Plomp AS, Hu X, de Jong PT, Gorgels TG: ABCC6 and pseudoxanthoma elasticum. Pflugers Arch 2007;453:685-691.
8. Pfendner EG, Vanakker OM, Terry SF, Vourthis S, McAndrew PE, McClain MR, et al: Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J Med Genet 2007;44:621-628.
9. Vanakker OM, Leroy B P, Coucke P, Bercovitch LG, Uitto J, Viljoen D, et al: Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart. Hum Mutat 2008;29:205.
10. Gorgels TG, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PT, et al: Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 2005;14:1763-1773.
11. Zarbock R, Hendig D, Szliska C, Kleesiek K, Gotting C: Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum. Hum Mol Genet 2009;18:3344-3351.
12. Neldner KH: Pseudoxanthoma elasticum. Clin Dermatol 1988;6:1-159.
13. Neldner KH: Pseudoxanthoma elasticum. Int J Dermatol 1988;27:98-100.
14. Lebwohl M, Neldner K, Pope FM, De Paepe A, Christiano AM, Boyd CD, et al: Classification of pseudoxanthoma elasticum: report of a consensus conference. J Am Acad Dermatol 1994;30:103-107.
15. Lafaut BA, Priem H, De Laey JJ: Indocyanine green angiography in angioid streaks. Bull Soc Belge Ophtalmol 1997;265:21-24.
16. Lafaut BA, Leys AM, Scassellati-Sforzolini B, Priem H, De Laey JJ: Comparison of fluorescein and indocyanine green angiography in angioid streaks. Graefes Arch Clin Exp Ophthalmol 1998;236:346-353.
17. Mansour AM, Ansari NH, Shields JA, Annesley WH Jr, Cronin CM, Stock EL: Evolution of angioid streaks. Ophthalmologica 1993;207:57-61.
18. Finger R P, Charbel IP, Ladewig M, Gotting C, Holz FG, Scholl HP: Fundus autofluorescence in pseudoxanthoma elasticum. Retina 2009;29:1496-1505.
19. Hu X, Plomp AS, van SS, Wijnholds J, de Jong PT, Bergen AA: Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol 2003;48:424-438.
20. Mansour AM, Annesley WH: Comet-tailed drusen of the retinal pigment epithelium in angioid streaks. Eye (Lond) 1998;12:943-944.
21. Pierro L, Brancato R, Minicucci M, Pece A: Echographic diagnosis of drusen of the optic nerve head in patients with angioid streaks. Ophthalmologica 1994;208:239-242.
22. Popescu MP: Presence of choroidal neovascular membranes in pseudoxanthoma elasticum. Rev Chir Oncol Radiol ORL Oftalmol Stomatol Ser Oftalmol 1987;31:219-220.
23. Puig J, Garcia-Arumi J, Salvador F, Sararols L, Calatayud M, Alforja S: Subretinal neovascularization and hemorrhages in angioid streaks (in Spanish). Arch Soc Esp Oftalmol 2001;76:309-314.
24. Soutome N, Sugahara M, Okada AA, Hida T: Subretinal hemorrhages after blunt trauma in pseudoxanthoma elasticum. Retina 2007;27:807-808.
25. Atmaca LS, Ozmert E: Macular involvement in angioid streaks. Gronblad-Strandberg syndrome (in French). J Fr Ophtalmol 1992;15:249-253.
26. Donaldson EJ: Angioid streaks. Aust J Ophthalmol 1983;11:55-58.
27. Sato K, Ikeda T: Fluorescein angiographic features of neovascular maculopathy in angioid streaks. Jpn J Ophthalmol 1994;38:417-422.
28. Schiano LD, Parravano MC, Chiaravalloti A, Varano M: Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up. Eur J Ophthalmol 2009;19:151-153.
29. Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, et al: Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Ophthalmology 2005;112:1227-1231.
30. Chung AK, Gauba V, Ghanchi FD: Photodynamic therapy using verteporfin for juxtafoveal choroidal neovascularisation in angioid streaks associated with pseudoxanthoma elasticum: 40 months' results. Eye (Lond) 2006;20:629-631.
31. Hedaya J, Freeman WR: The effect of treatments given to patients before initiation of antivascular endothelial growth factor treatment. Retina 2008;28:911-912.
32. Roth DB, Estafanous M, Lewis H: Macular translocation for subfoveal choroidal neovascularization in angioid streaks: Am J Ophthalmol 2001;131:390-392.
33. Singerman LJ, Hatem G: Laser treatment of choroidal neovascular membranes in angioid streaks. Retina 1981;1:75-83.
34. Tassignon MJ, Merckaert I, De CA, Cornelis MT: Treatment of choroidal neovascular membranes in a case of pseudoxanthoma elasticum (in French). Bull Soc Belge Ophtalmol 1985;214:107-112.
35. Menchini U, Virgili G, Introini U, Bandello F, Ambesi-Impiombato M, Pece A, et al: Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina 2004;24:763-771.
36. Bhatnagar P, Freund KB, Spaide RF, Klancnik JM Jr, Cooney MJ, Ho I, et al: Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 2007;27:897-902.
37. Derriman L, Marshall J, Moorman C, Downes SM: The use of intravitreal bevacizumab to treat choroidal neovascular membranes. Retina 2008;28:910-911.
38. Donati MC, Virgili G, Bini A, Giansanti F, Rapizzi E, Giacomelli G, et al: Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series. Ophthalmologica 2009;223:24-27.
39. Finger R P, Charbel I P, Ladewig M, Holz FG, Scholl HP: Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum. Br J Ophthalmol 2008;92:483-487.
40. Japiassu RM, Japiassu MA, Pecego MG: Intravitreal bevacizumab in choroidal neovascularization secondary to Gronblad-Strandberg syndrome: case report. Arq Bras Oftalmol 2008;71:427-429.
41. Lommatzsch A: Management of choroidal vascularisation. Br J Ophthalmol 2008;92:445-446.
42. Myung JS, Bhatnagar P, Spaide RF, Klancnik JM Jr, Cooney MJ, Yannuzzi LA, et al: Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularisation in pseudoxanthoma elasticum. Retina 2009.
43. Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C: Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 2007;125:1422-1423.
44. Kovach JL, Schwartz SG, Hickey M, Puliafito CA: Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 2009;40:77-79.
45. Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S: Non-arteritic anterior ischemic optic neuropathy after intravitreal injection of bevacizumab (Avastin) for treatment of angioid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol 2009;247:1707-1710.